Tingzhi Qian
Nessuna posizione attualmente
Storia della carriera di Tingzhi Qian
Precedenti posizioni note di Tingzhi Qian
Società | Posizione | Inizio | Fine |
---|---|---|---|
Shanghai Fosun High-Tech Group Finance Co., Ltd.
Shanghai Fosun High-Tech Group Finance Co., Ltd. Financial ConglomeratesFinance Fosun Group Finance Corp., Ltd. provides financial products and services. Its services include financial consulting, guarantee and payment services for member units, insurance agency, entrusted loans and entrusted investments, bills acceptance and discounting, factoring, interbank lending, and fixed income investments. The company was founded in June 2011 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 01/01/2008 | 01/01/2013 |
XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | Direttore/Membro del Consiglio | - | - |
Formazione di Tingzhi Qian
Fudan University | Undergraduate Degree |
École des Hautes Études Commerciales de Paris | Graduate Degree |
Polytech Clermont-Ferrand | Graduate Degree |
Statistiche
Distribuzione geografica
Cina | 4 |
Francia | 3 |
Posizioni
Graduate Degree | 2 |
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
Settori
Consumer Services | 4 |
Finance | 2 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Shanghai Fosun High-Tech Group Finance Co., Ltd.
Shanghai Fosun High-Tech Group Finance Co., Ltd. Financial ConglomeratesFinance Fosun Group Finance Corp., Ltd. provides financial products and services. Its services include financial consulting, guarantee and payment services for member units, insurance agency, entrusted loans and entrusted investments, bills acceptance and discounting, factoring, interbank lending, and fixed income investments. The company was founded in June 2011 and is headquartered in Shanghai, China. | Finance |
Xynomic Pharmaceuticals Holdings, Inc.
Xynomic Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Xynomic Pharmaceuticals Holdings, Inc. is a clinical stage best-in-class oncology therapeutics biopharmaceutical company. It engages in licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. Its current pipeline mainly consists of 3 drug candidates; Xynomic owns global exclusive development, manufacturing and commercialization rights to each of these. Its lead drug candidate abexinostat is in global potentially pivotal clinical trials against renal cell carcinoma and non-Hodgkin's lymphoma. The company was founded by Yinglin Mark Xu on October 7, 2016 and is headquartered in Shanghai, China. | Health Technology |
- Borsa valori
- Insiders
- Tingzhi Qian
- Esperienza